Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gisela M Terwindt

Showing results (1-10 of 262) with videos related to

Pageof 27
Sort By:
The Lancet. Neurology|December 17, 2019
Emerging treatments for headache: advances in 2019Gisela M Terwindt
Cephalalgia : an International Journal of Headache|November 2, 2023
Response to Letter to the Editor, Comment on "Effect of COVID vaccinations on monthly migraine days"Britt van der Arend, Gisela M Terwindt,
Cephalalgia : an International Journal of Headache|July 15, 2020
The potential danger of blocking CGRP for treating migraine in CADASIL patientsIrene de Boer, Antoinette MaassenVanDenBrink, Gisela M Terwindt
Brain : a Journal of Neurology|November 30, 2019
Reply: OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraineJudith A Pijpers, Michel D Ferrari, Gisela M Terwindt
Neurology|August 20, 2017
Medication overuse headache: An ongoing debateMark A Louter, Matthew S Robbins, Gisela M Terwindt
Neurology|June 16, 2017
Chronic headache: What's in a name?Mark A Louter, Thomas N Ward, Gisela M Terwindt
Handbook of Clinical Neurology|February 2, 2024
Hemiplegic migraineIrene de Boer, Jakob M Hansen, Gisela M Terwindt
Cephalalgia : an International Journal of Headache|June 25, 2026
Placebo or active comparator in chronic migraine trials: Balancing evidence and practicalityNancy van Veelen, Raffaele Ornello, Gisela M Terwindt, et al.
Molecular Neurobiology|March 30, 2023
Glia Signaling and Brain Microenvironment in MigraineHanieh Amani, Alireza Soltani Khaboushan, Gisela M Terwindt, et al.
Genome Medicine|February 24, 2018
Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatmentAntoinette MaassenVanDenBrink, Gisela M Terwindt, Arn M J M van den Maagdenberg
Pageof 27

Showing results (1-10 of 262) with videos related to

Sort By:
Pageof 27
The Lancet. Neurology|December 17, 2019
Emerging treatments for headache: advances in 2019Gisela M Terwindt
Cephalalgia : an International Journal of Headache|November 2, 2023
Response to Letter to the Editor, Comment on "Effect of COVID vaccinations on monthly migraine days"Britt van der Arend, Gisela M Terwindt,
Cephalalgia : an International Journal of Headache|July 15, 2020
The potential danger of blocking CGRP for treating migraine in CADASIL patientsIrene de Boer, Antoinette MaassenVanDenBrink, Gisela M Terwindt
Brain : a Journal of Neurology|November 30, 2019
Reply: OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraineJudith A Pijpers, Michel D Ferrari, Gisela M Terwindt
Neurology|August 20, 2017
Medication overuse headache: An ongoing debateMark A Louter, Matthew S Robbins, Gisela M Terwindt
Neurology|June 16, 2017
Chronic headache: What's in a name?Mark A Louter, Thomas N Ward, Gisela M Terwindt
Handbook of Clinical Neurology|February 2, 2024
Hemiplegic migraineIrene de Boer, Jakob M Hansen, Gisela M Terwindt
Cephalalgia : an International Journal of Headache|June 25, 2026
Placebo or active comparator in chronic migraine trials: Balancing evidence and practicalityNancy van Veelen, Raffaele Ornello, Gisela M Terwindt, et al.
Molecular Neurobiology|March 30, 2023
Glia Signaling and Brain Microenvironment in MigraineHanieh Amani, Alireza Soltani Khaboushan, Gisela M Terwindt, et al.
Genome Medicine|February 24, 2018
Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatmentAntoinette MaassenVanDenBrink, Gisela M Terwindt, Arn M J M van den Maagdenberg
Pageof 27